We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Celoxica | LSE:CXA | London | Ordinary Share | GB00B0L9TZ33 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.20 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number : 1404C
Celoxica Holdings PLC
27 August 2008
27 August 2008
CELOXICA HOLDINGS PLC
("Celoxica" or the "Company")
Additional Listing
The Company announces that application has been made for the admission to AIM of 1,150,000 new ordinary shares of 1p each in the Company
("Ordinary Share"), pursuant to an additional subscription for cash following the Company's fundraising announced on 29 April 2008. The new
Ordinary Share ranks pari passu with the Company's existing issued ordinary shares, and dealings are expected to commence on 27 August
2008.
Following Admission, the Company's enlarged issued share capital will comprise 285,457,435 ordinary shares with voting rights. The
Company does not hold any shares in treasury. This figure of 285,457,435 ordinary shares may be used by shareholders in the Company as the
denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their
interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.
ENQUIRIES
Celoxica Holdings plc (www.celoxica.com) Tel. +44 (0)1235 863 656
Lee Staines, CEO
Arbuthnot Securities Limited Tel. +44 (0) 20 7012 2000
Tom Griffiths
Alasdair Younie
END
This information is provided by RNS
The company news service from the London Stock Exchange
END
LISZDLFLVVBFBBE
1 Year Celoxica Chart |
1 Month Celoxica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
